The company's revenue jumped 77% in Q3 to reach $401.6 million in Q3 2024, alongside a net income of $75.6 million. It now ...
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...
Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders ...
Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...
Digital health companies faced high advertising costs and focused on returns on investments in the third quarter.
Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its ...
Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...
Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback